Provided by Tiger Fintech (Singapore) Pte. Ltd.

Impact Biomedical, Inc.

0.9300
-0.2800-23.14%
Volume:42.32K
Turnover:44.14K
Market Cap:10.70M
PE:76.97
High:1.34
Open:1.25
Low:0.8316
Close:1.21
Loading ...

Impact BioMedical CEO says ‘well-positioned’ to drive long-term value

TIPRANKS
·
19 Nov 2024

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

GlobeNewswire
·
19 Nov 2024

Universal Ibogaine Seeks Trade Order Amid Filing Delays

TIPRANKS
·
19 Nov 2024

BRIEF-Impact BioMedical Announces Issuance Of Canadian Patent For Linebacker Technology Targeting Inflammatory Disease

Reuters
·
15 Oct 2024

Impact Biomedical Inc - Canadian Patent Term Expires in May 2037

THOMSON REUTERS
·
15 Oct 2024

Impact Biomedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

THOMSON REUTERS
·
15 Oct 2024

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

GlobeNewswire
·
15 Oct 2024

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

GlobeNewswire
·
07 Oct 2024

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

GlobeNewswire
·
26 Sep 2024

Press Release: Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

Dow Jones
·
23 Sep 2024

Impact BioMedical Closes Initial Public Offering

MT Newswires Live
·
18 Sep 2024

Impact Biomedical Inc. Announces the Closing of Its Initial Public Offering

THOMSON REUTERS
·
17 Sep 2024

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

GlobeNewswire
·
17 Sep 2024

BRIEF-Impact Biomedical Inc. Announces Pricing Of Initial Public Offering

Reuters
·
17 Sep 2024

Impact BioMedical Shares Fall on Market Debut

MT Newswires Live
·
17 Sep 2024

Impact Biomedical Inc - Prices IPO at $3.00 per Share

THOMSON REUTERS
·
16 Sep 2024